Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on TreatmentNerea Vega‐García, Mireia Camós, Sara Pérez‐Jaume et al.|Frontiers in Pediatrics|2021Cited by 9
Abstract 3488: External validation of lysyl oxidase-like 2 (LOXL2) as a novel prognostic marker for gastro-entero-pancreatic neuroendocrine tumors (GEP-NET)Jorge Barriuso, Marta Mendiola, Laura Guerra et al.|Cancer Research|2016Cited by 0